Sandu Pharmaceuticals reports standalone net profit of Rs 0.30 crore in the March 2018 quarter

Sales rise 15.16% to Rs 12.23 crore

Net profit of Sandu Pharmaceuticals reported to Rs 0.30 crore in the quarter ended March 2018 as against net loss of Rs 1.10 crore during the previous quarter ended March 2017. Sales rose 15.16% to Rs 12.23 crore in the quarter ended March 2018 as against Rs 10.62 crore during the previous quarter ended March 2017.

For the full year,net profit reported to Rs 0.56 crore in the year ended March 2018 as against net loss of Rs 0.44 crore during the previous year ended March 2017. Sales rose 14.45% to Rs 49.02 crore in the year ended March 2018 as against Rs 42.83 crore during the previous year ended March 2017.

ParticularsQuarter EndedYear EndedMar. 2018Mar. 2017% Var.Mar. 2018Mar. 2017% Var.Sales12.2310.62 15 49.0242.83 14 OPM %6.87-5.46 -5.044.53 - PBDT0.64-0.88 LP 1.360.84 62 PBT0.40-1.10 LP 0.76-0.03 LP NP0.30-1.10 LP 0.56-0.44 LP

Powered by Capital Market - Live News